Breaking News Headlines Today | Ground News

institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

ajmc.com image

News from ajmc.com

ajmc.com’s aggregated media bias check is unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check.

ajmc.com’s aggregated factuality score is Unknown. Factuality is assigned by combining fact check, credibility, and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about ajmc.com

Where is ajmc.com located?ajmc.com's Website

Media Bias Ratings

Do you disagree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top ajmc.com News

Trump, AstraZeneca announce US drug pricing deal at White House — REUTERS / pwu404

US Politics · United States

Trump, AstraZeneca announce US drug pricing deal at White House

62% Center coverage: 146 sources

President Donald Trump unveiled a deal with UK-based drugmaker AstraZeneca on Friday under which the company will sell some medicines at a discount to the government's Medicaid health plan in exchange for tariff relief, similar to a drug pricing pact reached last week with Pfizer.See the Story

Spread of Drug-Resistant Superbugs Surging, WHO Warns — REUTERS / ixx511

World Health Organization · Geneva

Spread of Drug-Resistant Superbugs Surging, WHO Warns

64% Center coverage: 36 sources

The World Health Organization sounded the alarm Monday over soaring numbers of drug-resistant bacterial infections, compromising the effectiveness of life-saving treatments and rendering minor injuries and common infections potentially deadly.See the Story

FDA Tweaks JAK Inhibitor Indication in Inflammatory Bowel Disease

FDA · Columbia

FDA Tweaks JAK Inhibitor Indication in Inflammatory Bowel Disease

91% Center coverage: 11 sources

(MedPage Today) -- The FDA updated the indication of the JAK inhibitor upadacitinib (Rinvoq) in inflammatory bowel disease (IBD) to account for cases where a patient may not be appropriate for a TNF blocker, drugmaker AbbVie announced on Monday...See the Story

Breaking News Topics Related to ajmc.com